#24: Jason: Ceragenix Pharmaceuticals to Present at The Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th
Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a biopharmaceutical company focused... |
October 31, 2007
12:13:07 PM |
#23: NewsBot: CGXP News International Ophthalmology Conference to Feature Ceragenix's Anti-Microbial Technology
DENVER--(BUSINESS WIRE)--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP) today... |
February 26, 2007
10:16:00 AM |
#22: NewsBot: CGXP News Ceragenix Completes Patient Visits for EpiCeram(TM) Clinical Study
DENVER--(BUSINESS WIRE)--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a... |
February 21, 2007
05:45:00 AM |
#21: NewsBot: CGXP News Ceragenix Provides Update on Clinical Study
DENVER--(BUSINESS WIRE)--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), a... |
January 17, 2007
05:35:00 AM |
#20: NewsBot: CGXP News Ceragenix Completes $5 Million Financing
DENVER--(BUSINESS WIRE)--Ceragenix Pharmaceuticals, Inc. (OTCBB:CGXP), an emerging... |
December 11, 2006
07:30:00 AM |
#19: NewsBot: CGXP News Research on Ceragenins to Be Highlighted at Leading International Conference on Infectious Disease
DENVER--(BUSINESS WIRE)--Sept. 20, 2006--Ceragenix Pharmaceuticals, Inc., a... |
September 20, 2006
04:45:00 AM |
#18: NewsBot: CGXP News Ceragenix Pharmaceuticals Initiates EpiCeram(R) Clinical Trial; EpiCeram(R) to be Compared to Mid-Strength Steroid in Children with Moderate-to-Severe Eczema
DENVER--(BUSINESS WIRE)--Aug. 14, 2006--Ceragenix Pharmaceuticals, Inc., a... |
August 14, 2006
05:30:00 AM |
#17: NewsBot: CGXP News Ceragenix Pharmaceuticals Provides Mid-Year Update; Company Commencing Post-510k Clearance Studies for EpiCeram(R) to Support Current Partnering Discussions
DENVER--(BUSINESS WIRE)--Aug. 3, 2006-- Infectious Disease Programs Focused... |
August 3, 2006
05:30:00 AM |
#16: NewsBot: CGXP News Research on Use of Ceragenins(TM) as Potential Therapy for Behcet's Disease to Be Presented at International Conference in Lisbon
DENVER--(BUSINESS WIRE)--July 31, 2006--Ceragenix Pharmaceuticals, Inc., a... |
July 31, 2006
05:00:00 AM |
#15: NewsBot: CGXP News Research on Use of Ceragenins(TM) As Potential Therapy for Cystic Fibrosis Related Infections and Other Diseases to be Presented at ICAAC 2006
DENVER--(BUSINESS WIRE)--July 26, 2006--Ceragenix Pharmaceuticals, Inc. a... |
July 26, 2006
05:00:00 AM |
#14: NewsBot: CGXP News Ceragenix Obtains IRB Approval for Eczema Clinical Study; Study to Compare EpiCeram(R) to Mid-Strength Topical Steroid in Treatment of Children with Moderate-to-Severe Eczema
DENVER--(BUSINESS WIRE)--June 27, 2006--Ceragenix Pharmaceuticals, Inc., a... |
June 27, 2006
05:00:00 AM |
#13: NewsBot: CGXP News Ceragenix Enters Into Research and Development Agreement; Drugs Targeted Toward Prevention of Influenza Infection and Eradication of MRSA Bacterial Colonization
DENVER--(BUSINESS WIRE)--June 21, 2006--Ceragenix Pharmaceuticals, Inc., a... |
June 21, 2006
05:30:00 AM |
#12: NewsBot: CGXP Ceragenix, Stock Message Board, News, DD, Quote
Centers for Disease Control and Prevention (CDC) and Ceragenix Enter into a... |
February 11, 2006
09:28:39 AM |
#11: NewsBot: CGXP News In Vitro Study Results Show Ceragenix's Lead Antibiotic Compound Has Greater Bactericidal Activity against Potentially Lethal Bacterial Infections Than Leading Commonly-Prescribed Antibiotic Treatments
DENVER--(BUSINESS WIRE)--Dec. 21, 2005--Studies presented at the 45th Interscience... |
December 21, 2005
02:00:00 AM |
#10: NewsBot: CGXP News Ceragenix Presents Positive Data on its Novel Antimicrobial Medical Device Coating at International Conference on Infectious Diseases
DENVER--(BUSINESS WIRE)--Dec. 20, 2005--Ceragenix Pharmaceuticals, Inc.... |
December 20, 2005
03:07:00 AM |
| 
| 
| 
| 
| 
| 
